JP2014205701A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2014205701A5 JP2014205701A5 JP2014129106A JP2014129106A JP2014205701A5 JP 2014205701 A5 JP2014205701 A5 JP 2014205701A5 JP 2014129106 A JP2014129106 A JP 2014129106A JP 2014129106 A JP2014129106 A JP 2014129106A JP 2014205701 A5 JP2014205701 A5 JP 2014205701A5
- Authority
- JP
- Japan
- Prior art keywords
- composition
- composition according
- dosage form
- solid dosage
- therapeutically effective
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 239000000203 mixture Substances 0.000 claims 13
- HQKMJHAJHXVSDF-UHFFFAOYSA-L magnesium stearate Chemical compound [Mg+2].CCCCCCCCCCCCCCCCCC([O-])=O.CCCCCCCCCCCCCCCCCC([O-])=O HQKMJHAJHXVSDF-UHFFFAOYSA-L 0.000 claims 4
- 239000008194 pharmaceutical composition Substances 0.000 claims 4
- 239000007909 solid dosage form Substances 0.000 claims 4
- 239000004322 Butylated hydroxytoluene Substances 0.000 claims 3
- NLZUEZXRPGMBCV-UHFFFAOYSA-N Butylhydroxytoluene Chemical compound CC1=CC(C(C)(C)C)=C(O)C(C(C)(C)C)=C1 NLZUEZXRPGMBCV-UHFFFAOYSA-N 0.000 claims 3
- KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 claims 3
- 229940095259 butylated hydroxytoluene Drugs 0.000 claims 3
- 235000010354 butylated hydroxytoluene Nutrition 0.000 claims 3
- 241000193163 Clostridioides difficile Species 0.000 claims 2
- 206010012735 Diarrhoea Diseases 0.000 claims 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 claims 2
- 229920000168 Microcrystalline cellulose Polymers 0.000 claims 2
- 229920002472 Starch Polymers 0.000 claims 2
- 239000003963 antioxidant agent Substances 0.000 claims 2
- 229920001903 high density polyethylene Polymers 0.000 claims 2
- 239000004700 high-density polyethylene Substances 0.000 claims 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 claims 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 claims 2
- 229940071676 hydroxypropylcellulose Drugs 0.000 claims 2
- 235000019359 magnesium stearate Nutrition 0.000 claims 2
- 229940057948 magnesium stearate Drugs 0.000 claims 2
- 229940016286 microcrystalline cellulose Drugs 0.000 claims 2
- 235000019813 microcrystalline cellulose Nutrition 0.000 claims 2
- 239000008108 microcrystalline cellulose Substances 0.000 claims 2
- 229940079832 sodium starch glycolate Drugs 0.000 claims 2
- 229920003109 sodium starch glycolate Polymers 0.000 claims 2
- 239000008109 sodium starch glycolate Substances 0.000 claims 2
- 229940032147 starch Drugs 0.000 claims 2
- 235000019698 starch Nutrition 0.000 claims 2
- 239000008107 starch Substances 0.000 claims 2
- 239000004255 Butylated hydroxyanisole Substances 0.000 claims 1
- 229940043253 butylated hydroxyanisole Drugs 0.000 claims 1
- 235000019282 butylated hydroxyanisole Nutrition 0.000 claims 1
- CZBZUDVBLSSABA-UHFFFAOYSA-N butylated hydroxyanisole Chemical compound COC1=CC=C(O)C(C(C)(C)C)=C1.COC1=CC=C(O)C=C1C(C)(C)C CZBZUDVBLSSABA-UHFFFAOYSA-N 0.000 claims 1
- 150000001875 compounds Chemical class 0.000 claims 1
- 238000013270 controlled release Methods 0.000 claims 1
- 229960004592 isopropanol Drugs 0.000 claims 1
- 239000000546 pharmaceutical excipient Substances 0.000 claims 1
- 230000000087 stabilizing effect Effects 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US88113707P | 2007-01-19 | 2007-01-19 | |
| US60/881,137 | 2007-01-19 |
Related Parent Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009546419A Division JP5635266B2 (ja) | 2007-01-19 | 2008-01-17 | 安定なチアクミシン組成物 |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2014205701A JP2014205701A (ja) | 2014-10-30 |
| JP2014205701A5 true JP2014205701A5 (https=) | 2015-07-16 |
| JP5995331B2 JP5995331B2 (ja) | 2016-09-21 |
Family
ID=39641896
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009546419A Active JP5635266B2 (ja) | 2007-01-19 | 2008-01-17 | 安定なチアクミシン組成物 |
| JP2014129106A Active JP5995331B2 (ja) | 2007-01-19 | 2014-06-24 | 安定なチアクミシン組成物 |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2009546419A Active JP5635266B2 (ja) | 2007-01-19 | 2008-01-17 | 安定なチアクミシン組成物 |
Country Status (22)
| Country | Link |
|---|---|
| US (2) | US20080176927A1 (https=) |
| EP (1) | EP2121716B1 (https=) |
| JP (2) | JP5635266B2 (https=) |
| KR (1) | KR101491729B1 (https=) |
| CN (2) | CN102015747A (https=) |
| BR (1) | BRPI0806713A8 (https=) |
| CA (1) | CA2676003C (https=) |
| CY (1) | CY1117237T1 (https=) |
| DK (1) | DK2121716T3 (https=) |
| ES (1) | ES2560669T3 (https=) |
| HR (1) | HRP20151438T1 (https=) |
| HU (1) | HUE028671T2 (https=) |
| IL (1) | IL199941A (https=) |
| MX (1) | MX2009007784A (https=) |
| NZ (1) | NZ578493A (https=) |
| PL (1) | PL2121716T3 (https=) |
| PT (1) | PT2121716E (https=) |
| RU (1) | RU2484829C2 (https=) |
| SI (1) | SI2121716T1 (https=) |
| TW (1) | TWI474820B (https=) |
| WO (1) | WO2008091518A1 (https=) |
| ZA (1) | ZA200905134B (https=) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7906489B2 (en) | 2004-05-14 | 2011-03-15 | Optimer Pharmaceuticals, Inc. | 18-membered macrocycles and analogs thereof |
| US7378508B2 (en) | 2007-01-22 | 2008-05-27 | Optimer Pharmaceuticals, Inc. | Polymorphic crystalline forms of tiacumicin B |
| TWI523654B (zh) | 2007-11-27 | 2016-03-01 | 默沙東藥廠 | 抗生素巨環化合物以及其製造及使用之方法 |
| BR112012029262A8 (pt) * | 2010-05-18 | 2018-06-12 | Merck Sharp & Dohme | Métodos de tratamento de infecção bacteriana recorrente |
| AU2011255630B2 (en) * | 2010-05-18 | 2015-04-30 | Merck Sharp & Dohme Llc | Treatment of Clostridium difficile infection in patients undergoing antibiotic therapy |
| KR101891357B1 (ko) * | 2010-06-02 | 2018-08-24 | 디퓨젼 파마슈티컬즈 엘엘씨 | 양극성 트랜스 카로티노이드의 경구용 제형 |
| EP2670407A4 (en) * | 2011-02-04 | 2014-07-23 | Optimer Pharmaceuticals Inc | TREATMENT OF BACTERIAL INFECTIONS |
| ITMI20120560A1 (it) | 2012-04-05 | 2013-10-06 | Olon Spa | Procedimento per la purificazione della tiacumicina b |
| JO3464B1 (ar) * | 2013-01-15 | 2020-07-05 | Astellas Pharma Europe Ltd | التركيبات الخاصة بمركبات التياكوميسين |
| US20150141356A1 (en) * | 2013-11-15 | 2015-05-21 | Optimer Pharmaceuticals, Inc. | Treatment of Clostridium Difficile Infection in High Risk Patients |
| WO2015127955A1 (en) | 2014-02-25 | 2015-09-03 | Olon S.P.A. | A new polymorph of tiacumicin b and process for preparation thereof |
| HRP20181756T1 (hr) * | 2014-05-09 | 2018-12-28 | Astellas Pharma Europe Ltd. | Režim liječenja sa spojem tiakumicina |
| CN110037992B (zh) * | 2019-05-28 | 2021-05-28 | 杭州华东医药集团新药研究院有限公司 | 一种稳定的非达霉素组合物 |
| CN112353774B (zh) * | 2020-11-17 | 2022-08-23 | 浙江汇能生物股份有限公司 | 一种那西肽风味咀嚼片及其制备方法及其在犬魏氏梭菌病上的用途 |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH05192094A (ja) * | 1991-09-03 | 1993-08-03 | Takeda Chem Ind Ltd | 造粒組成物 |
| US5583115A (en) * | 1995-05-09 | 1996-12-10 | Abbott Laboratories | Dialkyltiacumicin compounds |
| WO2002032427A1 (en) * | 2000-10-20 | 2002-04-25 | Galephar M/F | Stable oral formulation containing benzimidazole derivative |
| US20030099699A1 (en) * | 2001-11-13 | 2003-05-29 | Hanshew Dwight D. | Storage stable thyroxine active drug formulations and methods for their production |
| AU2003251902B2 (en) * | 2002-07-29 | 2008-03-06 | Merck Sharp & Dohme Llc | Tiacumicin production |
| US9211259B2 (en) | 2002-11-29 | 2015-12-15 | Foamix Pharmaceuticals Ltd. | Antibiotic kit and composition and uses thereof |
| EP1572164A2 (en) * | 2002-12-18 | 2005-09-14 | Pain Therapeutics, Inc. | Oral dosage forms with therapeutically active agents in controlled release cores and immediate release gelatin capsule coats |
| US7906489B2 (en) * | 2004-05-14 | 2011-03-15 | Optimer Pharmaceuticals, Inc. | 18-membered macrocycles and analogs thereof |
| JP5166040B2 (ja) * | 2005-01-31 | 2013-03-21 | オプティマー ファーマシューティカルズ、インコーポレイテッド | １８員大環状化合物及びその類似化合物 |
-
2008
- 2008-01-14 US US12/008,751 patent/US20080176927A1/en not_active Abandoned
- 2008-01-17 DK DK08724557.7T patent/DK2121716T3/en active
- 2008-01-17 HR HRP20151438TT patent/HRP20151438T1/hr unknown
- 2008-01-17 JP JP2009546419A patent/JP5635266B2/ja active Active
- 2008-01-17 ES ES08724557.7T patent/ES2560669T3/es active Active
- 2008-01-17 CN CN2008800078761A patent/CN102015747A/zh active Pending
- 2008-01-17 CA CA2676003A patent/CA2676003C/en active Active
- 2008-01-17 WO PCT/US2008/000591 patent/WO2008091518A1/en not_active Ceased
- 2008-01-17 BR BRPI0806713A patent/BRPI0806713A8/pt not_active Application Discontinuation
- 2008-01-17 RU RU2009128612/15A patent/RU2484829C2/ru active
- 2008-01-17 HU HUE08724557A patent/HUE028671T2/en unknown
- 2008-01-17 NZ NZ578493A patent/NZ578493A/en unknown
- 2008-01-17 PL PL08724557T patent/PL2121716T3/pl unknown
- 2008-01-17 KR KR1020097017319A patent/KR101491729B1/ko not_active Expired - Fee Related
- 2008-01-17 CN CN201510502516.0A patent/CN105169396A/zh active Pending
- 2008-01-17 EP EP08724557.7A patent/EP2121716B1/en active Active
- 2008-01-17 SI SI200831576T patent/SI2121716T1/sl unknown
- 2008-01-17 MX MX2009007784A patent/MX2009007784A/es active IP Right Grant
- 2008-01-17 PT PT87245577T patent/PT2121716E/pt unknown
- 2008-03-10 TW TW097108321A patent/TWI474820B/zh active
-
2009
- 2009-07-19 IL IL199941A patent/IL199941A/en active IP Right Grant
- 2009-07-22 ZA ZA2009/05134A patent/ZA200905134B/en unknown
-
2012
- 2012-03-09 US US13/416,768 patent/US20130065844A1/en not_active Abandoned
-
2014
- 2014-06-24 JP JP2014129106A patent/JP5995331B2/ja active Active
-
2016
- 2016-03-01 CY CY20161100177T patent/CY1117237T1/el unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2014205701A5 (https=) | ||
| JP2015078230A5 (https=) | ||
| ZA202303338B (en) | Orodispersible dosage unit containing an estetrol component | |
| JP2010516677A5 (https=) | ||
| NZ711179A (en) | Oral formulations of deferasirox | |
| RU2017109139A (ru) | Таблетки, содержащие большую дозу рукапариба | |
| JP2018162255A5 (https=) | ||
| PE20161373A1 (es) | Composiciones de liberacion retardada de linaclotida | |
| JP2015523407A5 (https=) | ||
| NZ720906A (en) | Orally disintegrating solid dosage unit containing an estetrol component | |
| JP2015038135A5 (https=) | ||
| RU2014143536A (ru) | Фармацевтическая композиция, содержащая омелсартана медоксомил и розувастатин или его соль | |
| JP2015511635A5 (https=) | ||
| JP2015510916A5 (https=) | ||
| AR077546A1 (es) | Formulaciones de comprimidos de 3-cianoquinolina y usos de los mismos | |
| NZ628993A (en) | Pharmaceutical formulations comprising ccr3 antagonists | |
| SA517390550B1 (ar) | وحدة جرعة قابلة للتفتت في الفم تتضمن مكون أستيترول | |
| CA2676003A1 (en) | Compositions of stable tiacumicins | |
| AR100977A1 (es) | Formulación compuesta para la administración oral que comprende ezetimiba y rosuvastatina, y un proceso para su preparación | |
| JP2014221827A5 (https=) | ||
| PH12014501408A1 (en) | Immediate release multi unit pellet system | |
| AR091621A1 (es) | Formas de presentacion farmaceuticas que contienen 5-cloro-n-({(5s)-2-oxo-3-[4-(3-oxo-4-morfolinil)-fenil]-1,3-oxazolidin-5-il}-metil)-2-tiofen-carboxamida | |
| MX374106B (es) | Una composicion farmaceutica que contiene candesartan cilexetilo y amlodipina. | |
| JP2017520619A5 (https=) | ||
| JP2013528213A5 (https=) |